Meloxicam Market Outlook:
Meloxicam Market size was over USD 7.64 billion in 2025 and is projected to reach USD 12.21 billion by 2035, growing at around 4.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of meloxicam is evaluated at USD 7.97 billion.
The growth of this market can be attributed to the back of increasing prevalence of osteoarthritis, juvenile rheumatoid arthritis, and rheumatoid arthritis especially among the old population. Meloxicam is an effective pain management medication highly used in the treatment of the above health problems. In this health issue when doctors initiate surgeries the post-surgery pain is always at a high range and is too much painful in order to offer relief from this pain to patients doctors use pain management medications such as meloxicam. Thus, the increasing incidence of these diseases is raising the demand for meloxicam market in the projected time period. As per a report by the World Health Organization, 60% of those who have osteoarthritis are female and 73% are older than 55. The knee is the joint that is most frequently affected, with an estimated number of 365 million, next to the hip and the hand.
Furthermore, the growth of the market can also be driven by increasing awareness about the availability of pain relief medication. In the past few times, there has been a surge in awareness about pain relief medication available in the market among the population. This is predicted to boost the market growth of meloxicam in the projection time period.
